Page 46 - IJB-9-6

International Journal of Bioprinting Transdermal delivery of printed cisplatin

20. Lan X, Zhu W, Huang X, et al., 2020, Microneedles loaded loaded microneedle arrays against methicillin-resistant
with anti-PD-1-cisplatin nanoparticles for synergistic cancer Staphylococcus aureus skin infections. Adv Mater Technol,
immuno-chemotherapy. Nanoscale, 12(36): 18885–18898. 6(7): 2001307.
https://doi.org/10.1039/d0nr04213g https://doi.org/10.1002/admt.202001307
21. Lan X, She J, Lin DA, et al., 2018, Microneedle-mediated 32. Shaik AN, Altomare DA, Lesko LJ, et al., 2017, Development
delivery of lipid-coated cisplatin nanoparticles for efficient and validation of a LC-MS/MS assay for quantification of
and safe cancer therapy. ACS Appl Mater Interfaces, 10(39): cisplatin in rat plasma and urine. J Chromatogr B Analyt
33060–33069. Technol Biomed Life Sci, 1046(March): 243–249.
https://doi.org/10.1021/acsami.8b12926 https://doi.org/10.1016/j.jchromb.2016.11.027
22. Fu JJ, Li CW, Liu Y, et al., 2020, The microneedles 33. Coughlan AM, Harmon C, Whelan S, et al., 2016, Myeloid
carrying cisplatin and IR820 to perform synergistic engraftment in humanized mice: Impact of granulocyte-
chemo-photodynamic therapy against breast cancer. J colony stimulating factor treatment and transgenic mouse
Nanobiotechnol, 18(1): 146. strain. Stem Cells Dev, 25(7): 530–541.
https://doi.org/10.1186/s12951-020-00697-0 https://doi.org/10.1089/scd.2015.0289
23. Uddin MJ, Scoutaris N, Klepetsanis P, et al., 2015, Inkjet 34. Shultz LD, Lyons BL, Burzenski LM, et al., 2005, Human
printing of transdermal microneedles for the delivery of lymphoid and myeloid cell development in NOD/LtSz-scid
anticancer agents. Int J Pharm, 494(2): 593–602. IL2R gamma null mice engrafted with mobilized human
hemopoietic stem cells. J Immunol, 174(10): 6477–6489.
https://doi.org/10.1016/j.ijpharm.2015.01.038
https://doi.org/10.4049/jimmunol.174.10.6477
24. Ross S, Scoutaris N, Lamprou D, et al., 2015, Inkjet printing
of insulin microneedles for transdermal delivery. Drug Deliv 35. Kanaki Z, Voutsina A, Markou A, et al., 2021, Generation
Transl Res, 5(4): 451–461. of non-small cell lung cancer patient-derived xenografts to
study intratumor heterogeneity. Cancers (Basel), 13(10).
https://doi.org/10.1007/s13346-015-0251-1
https://doi.org/10.3390/cancers13102446
25. Uddin MJ, Scoutaris N, Economidou SN, et al., 2020,
3D printed microneedles for anticancer therapy of skin 36. Falcon-Suarez IH, Livo K, Callow B, et al., 2020, Geophysical
tumours. Mater Sci Eng C Mater Biol Appl, 107(February): early warning of salt precipitation during geological carbon
110248. sequestration. Sci Rep, 10(1): 16472.
https://doi.org/10.1016/j.msec.2019.110248 https://doi.org/10.1038/s41598-020-73091-3
26. Tarbox TN, Watts AB, Cui Z, et al., 2018, An update on 37. Johnsson A, Olsson C, Nygren O, et al., 1995,
coating/manufacturing techniques of microneedles. Drug Pharmacokinetics and tissue distribution of cisplatin in
Deliv Transl Res, 8(6): 1828–1843. nude mice: Platinum levels and cisplatin-DNA adducts.
Cancer Chemother Pharmacol, 37(1–2): 23–31.
https://doi.org/10.1007/s13346-017-0466-4
https://doi.org/10.1007/BF00685625
27. Haj-Ahmad R, Khan H, Arshad MS, et al., 2015,
Microneedle coating techniques for transdermal drug 38. Rampias T, Karagiannis D, Avgeris M, et al., 2019, The
delivery. Pharmaceutics, 7(4): 486–502. lysine-specific methyltransferase KMT2C/MLL3 regulates
DNA repair components in cancer. EMBO Rep, 20(3).
https://doi.org/10.3390/pharmaceutics7040486
https://doi.org/10.15252/embr.201846821
28. Papazoglou S, Zergioti I, 2017, Laser induced forward
transfer (LIFT) of nano-micro patterns for sensor 39. Ray Chaudhuri A, Callen E, Ding X, et al., 2016, Replication
applications. Microelectron Eng, 182(October): 25–34. fork stability confers chemoresistance in BRCA-deficient
cells. Nature, 535(7612): 382–387.
https://doi.org/10.1016/j.mee.2017.08.003
https://doi.org/10.1038/nature18325
29. Kanaki Z, Chandrinou C, Orfanou IM, et al., 2022, Laser-
induced forward transfer printing on microneedles for 40. Chang A, Liu L, Ashby JM, et al., 2021, Recruitment of
transdermal delivery of gemcitabine. Int J Bioprint, 8(2): 554. KMT2C/MLL3 to DNA damage sites mediates DNA damage
responses and regulates PARP inhibitor sensitivity in cancer.
https://doi.org/10.18063/ijb.v8i2.554 Cancer Res, 81(12): 3358–3373.
30. Hall MD, Telma KA, Chang KE, et al., 2014, Say no to DMSO: https://doi.org/10.1158/0008-5472.CAN-21-0688
dimethylsulfoxide inactivates cisplatin, carboplatin, and other
platinum complexes. Cancer Res, 74(14): 3913–3922. 41. Diossy M, Sztupinszki Z, Borcsok J, et al., 2021, A subset
of lung cancer cases shows robust signs of homologous
https://doi.org/10.1158/0008-5472.CAN-14-0247 recombination deficiency associated genomic mutational
31. Ziesmer J, Tajpara P, Hempel NJ, et al., 2021, Vancomycin- signatures. NPJ Precis Oncol, 5(1): 55.

Volume 9 Issue 6 (2023) 38 https://doi.org/10.36922/ijb.0048